Creating a new way to generate antibodies for various proteins.
Proteome Scale Multiplexed Generation of Recombinant Antibodies
['FUNDING_OTHER'] · UNIVERSITY OF OREGON · NIH-11112654
This study is working on a new way to create antibodies that can help with diagnosing and treating diseases by using proteins from humans and zebrafish, making it easier and faster to produce these important tools for patients like you.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF OREGON (nih funded) |
| Locations | 1 site (EUGENE, UNITED STATES) |
| Trial ID | NIH-11112654 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a novel platform to generate antibodies against a wide range of proteins found in humans and zebrafish. By creating large libraries of genes that encode these proteins, the researchers aim to produce antibodies more efficiently and at a larger scale than current methods allow. This approach addresses the limitations of existing antibody generation techniques, which are often slow and labor-intensive. Patients may benefit from improved access to high-quality antibodies that can be used in diagnostics and therapeutics.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals requiring specific antibody-based treatments or diagnostics.
Not a fit: Patients who do not require antibody-based therapies or diagnostics may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the rapid development of high-quality antibodies that improve diagnostic and therapeutic options for patients.
How similar studies have performed: While there have been advancements in antibody generation, this approach is considered novel and aims to address significant limitations in current methodologies.
Where this research is happening
EUGENE, UNITED STATES
- UNIVERSITY OF OREGON — EUGENE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PLESA, CALIN — UNIVERSITY OF OREGON
- Study coordinator: PLESA, CALIN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.